首页> 外文期刊>HPB Surgery >Are Hepatic Adenomas Premalignant?
【24h】

Are Hepatic Adenomas Premalignant?

机译:肝腺瘤是否会恶变?

获取原文
       

摘要

Objective: To investigate clinical experience with the apparent malignant transformation of benign liver cell adenomas.Design: Retrospective review of personal experience and literature.Setting: University hospital and affiliated community hospitals.Patients: All patients diagnosed with liver cell adenomas over a 30-year period.Interventions: Liver resection and/or tumor biopsy.Main Outcome Measures: Gender, age, drug associations, alpha-fetoprotein levels, response to treatment, and survival.Results: Thirteen patients from personal experience and 26 patients from the reports of others had liver cell adenomas that were not resected. Five of these patients subsequently developed hepatocellular carcinoma.Conclusions: Malignant transformation of a liver cell adenoma is a rare phenomenon, but it does occur. Alphafetoprotein levels may be more helpful in diagnosis than expected from previous reports. Solitary benign adenomas should be resected whenever possible. Patients with diffuse multiple tumors should be observed closely over a long period.
机译:目的:探讨良性肝细胞腺瘤明显恶变的临床经验设计:个人经验和文献回顾性研究背景:大学医院和附属社区医院患者:所有被诊断患有肝细胞腺瘤的患者均超过30年干预措施:肝切除和/或肿瘤活检主要结果指标:性别,年龄,药物关联,甲胎蛋白水平,对治疗的反应和生存率结果:根据个人经验有13例患者,根据其他报告有26例患者肝细胞腺瘤未切除。这些患者中有五例随后发展为肝细胞癌。结论:肝细胞腺瘤的恶性转化是一种罕见现象,但确实会发生。甲胎蛋白水平可能比以前的报告预期的对诊断更有帮助。如有可能,应切除孤立性良性腺瘤。患有多个弥漫性肿瘤的患者应长期观察。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号